These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21795640)

  • 1. Metyrapone and fluoxetine suppress enduring behavioral but not cardiac effects of subchronic stress in rats.
    Carnevali L; Bondarenko E; Sgoifo A; Walker FR; Head GA; Lukoshkova EV; Day TA; Nalivaiko E
    Am J Physiol Regul Integr Comp Physiol; 2011 Oct; 301(4):R1123-31. PubMed ID: 21795640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic fluoxetine reduces autonomic control of cardiac rhythms in rats with congestive heart failure.
    Henze M; Tiniakov R; Samarel A; Holmes E; Scrogin K
    Am J Physiol Heart Circ Physiol; 2013 Feb; 304(3):H444-54. PubMed ID: 23220332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of chronic fluoxetine on social isolation-induced changes on sucrose consumption, immobility behavior, and on serotonin and dopamine function in hippocampus and ventral striatum.
    Brenes JC; Fornaguera J
    Behav Brain Res; 2009 Mar; 198(1):199-205. PubMed ID: 19027796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain.
    Berton O; Durand M; Aguerre S; Mormède P; Chaouloff F
    Neuroscience; 1999; 92(1):327-41. PubMed ID: 10392854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral tolerance to and withdrawal from multiple fluoxetine administration.
    Bjork JM; Gaytan O; Patt N; Swann AC; Dafny N
    Int J Neurosci; 1998 Apr; 93(3-4):163-79. PubMed ID: 9639233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian behavior of adult mice exposed to stress and fluoxetine during development.
    Kiryanova V; Smith VM; Dyck RH; Antle MC
    Psychopharmacology (Berl); 2017 Mar; 234(5):793-804. PubMed ID: 28028599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subchronic fluoxetine treatment induces a transient potentiation of amphetamine-induced hyperlocomotion: possible pharmacokinetic interaction.
    Sills TL; Greenshaw AJ; Baker GB; Fletcher PJ
    Behav Pharmacol; 2000 Apr; 11(2):109-16. PubMed ID: 10877115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine oral treatment discloses 5-HT
    López C; Gómez-Roso M; García-Pedraza JÁ; Martín ML; Morán A; García-Domingo M
    Can J Physiol Pharmacol; 2019 Feb; 97(2):90-98. PubMed ID: 30462556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects.
    Fletcher PJ; Sinyard J; Salsali M; Baker GB
    Psychopharmacology (Berl); 2004 Jul; 174(3):406-13. PubMed ID: 14740149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
    Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
    Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic fluoxetine treatment enhances sympathetic activities associated with abnormality of baroreflex function in conscious normal rats.
    Hong LZ; Huang KF; Hung SW; Kuo LT
    Eur J Pharmacol; 2017 Sep; 811():164-170. PubMed ID: 28629735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metyrapone reveals that previous chronic stress differentially impairs hippocampal-dependent memory.
    Conrad CD; Mauldin-Jourdain ML; Hobbs RJ
    Stress; 2001 Dec; 4(4):305-18. PubMed ID: 18301732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats.
    Zhang Y; Raap DK; Garcia F; Serres F; Ma Q; Battaglia G; Van de Kar LD
    Brain Res; 2000 Feb; 855(1):58-66. PubMed ID: 10650130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine-induced desensitization of somatodendritic 5-HT1A autoreceptors is independent of glucocorticoid(s).
    Le Poul E; Laaris N; Hamon M; Lanfumey L
    Synapse; 1997 Dec; 27(4):303-12. PubMed ID: 9372553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Rempel NL; Callaway CW; Geyer MA
    Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat.
    Herges S; Taylor DA
    Pharmacol Biochem Behav; 1998 Mar; 59(3):595-611. PubMed ID: 9512061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia.
    Grippo AJ; Beltz TG; Weiss RM; Johnson AK
    Biol Psychiatry; 2006 Feb; 59(4):309-16. PubMed ID: 16154542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat.
    Roche M; Harkin A; Kelly JP
    Neuropsychopharmacology; 2007 Jun; 32(6):1312-20. PubMed ID: 17119540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test.
    Rogóż Z; Kabziński M; Sadaj W; Rachwalska P; Gądek-Michalska A
    Pharmacol Rep; 2012; 64(6):1391-9. PubMed ID: 23406749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central serotonergic responses and behavioural adaptation to repeated immobilisation: the effect of the corticosterone synthesis inhibitor metyrapone.
    Kennett GA; Dickinson SL; Curzon G
    Eur J Pharmacol; 1985 Dec; 119(3):143-52. PubMed ID: 4092729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.